USA Mutuals Advisors Inc. purchased a new position in shares of Masimo Co. (NASDAQ:MASI) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,270 shares of the medical equipment provider’s stock, valued at approximately $110,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Sterling Capital Management LLC boosted its holdings in Masimo by 0.6% during the second quarter. Sterling Capital Management LLC now owns 7,803 shares of the medical equipment provider’s stock worth $711,000 after purchasing an additional 44 shares during the last quarter. 1st Global Advisors Inc. boosted its holdings in Masimo by 3.2% during the second quarter. 1st Global Advisors Inc. now owns 7,468 shares of the medical equipment provider’s stock worth $681,000 after purchasing an additional 233 shares during the last quarter. Advisor Group Inc. boosted its holdings in Masimo by 38.4% during the second quarter. Advisor Group Inc. now owns 2,361 shares of the medical equipment provider’s stock worth $216,000 after purchasing an additional 655 shares during the last quarter. Cardinal Capital Management boosted its holdings in Masimo by 2.7% during the third quarter. Cardinal Capital Management now owns 25,681 shares of the medical equipment provider’s stock worth $2,222,000 after purchasing an additional 678 shares during the last quarter. Finally, Strs Ohio boosted its holdings in Masimo by 3.7% during the third quarter. Strs Ohio now owns 19,700 shares of the medical equipment provider’s stock worth $1,705,000 after purchasing an additional 700 shares during the last quarter. Institutional investors and hedge funds own 82.57% of the company’s stock.

A number of research firms have weighed in on MASI. Zacks Investment Research cut shares of Masimo from a “buy” rating to a “hold” rating in a research note on Wednesday. BidaskClub cut shares of Masimo from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $108.00 target price on shares of Masimo in a research note on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the company. Masimo has a consensus rating of “Hold” and an average target price of $97.17.

Masimo Co. (MASI) opened at $83.47 on Friday. The firm has a market cap of $4,312.98, a PE ratio of 13.21, a price-to-earnings-growth ratio of 3.17 and a beta of 0.85. Masimo Co. has a 52 week low of $75.06 and a 52 week high of $104.71.

In other Masimo news, EVP Yongsam Lee sold 5,900 shares of the business’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $88.31, for a total value of $521,029.00. Following the transaction, the executive vice president now directly owns 70,800 shares in the company, valued at $6,252,348. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Sanford Fitch sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $93.07, for a total transaction of $186,140.00. Following the sale, the director now owns 68,249 shares in the company, valued at $6,351,934.43. The disclosure for this sale can be found here. Over the last quarter, insiders sold 48,098 shares of company stock worth $4,315,261. Corporate insiders own 16.60% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece of content was first reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece of content on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://theolympiareport.com/2018/02/11/usa-mutuals-advisors-inc-purchases-shares-of-1270-masimo-co-masi.html.

Masimo Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.